您的位置: 首页 > 农业专利 > 详情页

Processes for the Preparation of SGLT-2 Inhibitors, Intermediates Thereof
专利权人:
Emmennar Pharma Private Limited
发明人:
Maha Vishnu Mundla,Sridhar Malyala,Chandra Prakash Narani,Laxmi Narasimha Varaprasad Chintaginjala,Suresh Kumar Gunukula,Bala Yellaiah Chittiboyina,Prabhakar Bellam,Hemalatha Reddy Samireddy,Sowmya Da
申请号:
US15990860
公开号:
US20180346502A1
申请日:
2018.05.29
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to novel, improved processes for the preparation of sodium glucose co-transporter 2 (SGLT-2) inhibitors and novel intermediates thereof. More particularly, the present invention relates to a novel, improved process for the preparation of gliflozin compounds such as empagliflozin and dapagliflozin, intermediates thereof. The product obtained from the processes of present invention may be amorphous or crystalline, or in the form of amorphous/crystalline solid dispersions/solutions with pharmaceutically acceptable polymers and preparation process thereof. Also, the products obtained from the present invention may be used for the preparation of medicaments for the prevention and/or treatment of diseases and conditions associated with SGLT-2 inhibition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充